Risk of coronary heart disease in patients with HIV infection

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature Reviews Cardiology

• Publication date

  2014-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrcardio.2014.167PMID 25331088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in Socioeconomic Inequality of Low Birth Weight and Macrosomia in Shaanxi Province of Northwest China, 2010–2013

  2016cited by this paper
• A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2015cited by this paper
• Severe Morbidity According to Sex in the Era of Combined Antiretroviral Therapy: The ANRS CO3 Aquitaine Cohort

  2014cited by this paper
• Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy

  2014cited by this paper
• Transfer of Intracellular HIV Nef to Endothelium Causes Endothelial Dysfunction

  2014cited by this paper
• HIV envelope protein gp120-induced apoptosis in lung microvascular endothelial cells by concerted upregulation of EMAP II and its receptor, CXCR3.

  2014cited by this paper
• Associations Between HIV Infection and Subclinical Coronary Atherosclerosis

  2014cited by this paper
• Increased Arterial Inflammation Relates to High-Risk Coronary Plaque Morphology in HIV-Infected Patients

  2014cited by this paper
• HIV infection and incidence of ischemic stroke

  2014cited by this paper
• Hdl Redox Activity is Increased in HIV-Infected Men in Association with Macrophage Activation and Non-Calcified Coronary Atherosclerotic Plaque

  2014cited by this paper
• Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000

  2014cited by this paper
• Is there continued evidence for an association between abacavir and myocardial infarction risk

  2014cited by this paper
• Risk of Cardiovascular Disease Associated with HCV and HBV Coinfection among Antiretroviral-Treated HIV-Infected Individuals

  2014cited by this paper
• Efavirenz induces interactions between leucocytes and endothelium through the activation of Mac-1 and gp150,95.

  2014cited by this paper
• 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis

  2014cited by this paper
• Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection

  2014cited by this paper
• Associations Between HIV infection and Subclinical Coronary Atherosclerosis

  2014cited by this paper
• Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients

  2014cited by this paper
• Immunodeficiency and Risk of Myocardial Infarction Among HIV-Positive Individuals With Access to Care

  2014cited by this paper
• Deteriorating renal function and clinical outcomes in HIV-positive persons

  2014cited by this paper
• Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.

  2014cited by this paper
• Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America.

  2014cited by this paper
• Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.

  2014cited by this paper
• Lipoprotein‐associated phospholipase A2 and cardiovascular disease risk in HIV infection

  2014cited by this paper
• HIV and the heart: the impact of antiretroviral therapy: a global perspective.

  2013cited by this paper
• The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV- positive patients in Johannesburg, South Africa.

  2013cited by this paper
• The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults

  2013cited by this paper
• Comprehensive Cardiac Magnetic Resonance Imaging and Spectroscopy Reveal a High Burden of Myocardial Disease in HIV Patients

  2013cited by this paper
• HIV Tat Induces Expression of ICAM-1 in HUVECs: Implications for miR-221/-222 in HIV-Associated Cardiomyopathy

  2013cited by this paper
• Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection

  2013cited by this paper
• Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.

  2013cited by this paper
• HIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-α and IL-10

  2013cited by this paper
• HIV and coronary heart disease: time for a better understanding.

  2013cited by this paper
• Markers of inflammation and CD8 T‐cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV‐infected individuals

  2013cited by this paper
• Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men

  2013cited by this paper
• Associations between immune depression and cardiovascular events in HIV infection

  2013cited by this paper
• In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients

  2013cited by this paper
• Immune activation and HIV persistence: considerations for novel therapeutic interventions

  2013cited by this paper
• Differences between HIV‐infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case–control studies

  2013cited by this paper
• Management of human immunodeficiency virus infection in advanced age.

  2013cited by this paper
• Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events

  2013cited by this paper
• Platelet count kinetics following interruption of antiretroviral treatment

  2013cited by this paper
• HIV infection and the risk of acute myocardial infarction.

  2013cited by this paper
• The expression of cholesterol metabolism genes in monocytes from HIV-infected subjects suggests intracellular cholesterol accumulation.

  2013cited by this paper
• A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV.

  2013cited by this paper
• Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study.

  2013cited by this paper
• Efficacy of the CCR5 Antagonist Maraviroc in Reducing Early, Ritonavir-Induced Atherogenesis and Advanced Plaque Progression in Mice

  2013cited by this paper
• Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

  2013cited by this paper
• Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity.

  2013cited by this paper
• Aspirin Attenuates Platelet Activation and Immune Activation in HIV-1-Infected Subjects on Antiretroviral Therapy: A Pilot Study

  2013cited by this paper
• Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy.

  2013cited by this paper
• HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals.

  2012cited by this paper
• Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.

  2012cited by this paper
• Increased Platelet and Microparticle Activation in HIV Infection: Upregulation of P-Selectin and Tissue Factor Expression

  2012cited by this paper
• HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux[S]

  2012cited by this paper
• No Association of Abacavir Use With Myocardial Infarction: Findings of an FDA Meta-Analysis

  2012cited by this paper
• Microbial translocation in HIV infection: causes, consequences and treatment opportunities

  2012cited by this paper
• HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy

  2012cited by this paper
• HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group

  2012cited by this paper
• Arterial inflammation in patients with HIV.

  2012cited by this paper
• Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients.

  2012cited by this paper
• Potential Cardiovascular Disease Risk Markers Among HIV-Infected Women Initiating Antiretroviral Treatment

  2012cited by this paper
• Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population.

  2012cited by this paper
• Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome.

  2012cited by this paper
• Body composition and metabolic changes in HIV-infected patients.

  2012cited by this paper
• A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis

  2012cited by this paper
• Sudden cardiac death in patients with human immunodeficiency virus infection.

  2012cited by this paper
• Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care

  2012cited by this paper
• Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

  2012cited by this paper
• Management of the metabolic effects of HIV and HIV drugs

  2012cited by this paper
• Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients

  2012cited by this paper
• HIV and Africa's elderly: the problems and possibilities

  2012cited by this paper
• Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

  2012cited by this paper
• T-Cell Phenotypes, Apoptosis and Inflammation in HIV+ Patients on Virologically Effective cART with Early Atherosclerosis

  2012cited by this paper
• Elevated triglycerides and risk of myocardial infarction in HIV-positive persons

  2011cited by this paper
• Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy

  2011cited by this paper
• Abacavir increases platelet reactivity via competitive inhibition of soluble guanylyl cyclase

  2011cited by this paper
• Renal Issues in HIV Infection

  2011cited by this paper
• Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québec's Public Health Insurance Database

  2011cited by this paper
• Plasma levels of soluble CD14 independently predict mortality in HIV infection.

  2011cited by this paper
• Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study

  2011cited by this paper
• HIV‐1 Tat‐induced platelet activation and release of CD154 contribute to HIV‐1‐associated autoimmune thrombocytopenia

  2011cited by this paper
• T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women

  2011cited by this paper
• Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

  2011cited by this paper
• Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis.

  2011cited by this paper
• Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.

  2011cited by this paper
• Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE

  2011cited by this paper
• Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.

  2011cited by this paper
• HIV Protease Inhibitors Act as Competitive Inhibitors of the Cytoplasmic Glucose Binding Site of GLUTs with Differing Affinities for GLUT1 and GLUT4

  2011cited by this paper
• Hypertension and Obesity as Cardiovascular Risk Factors among HIV Seropositive Patients in Western Kenya

  2011cited by this paper
• Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

  2010cited by this paper
• HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells.

  2010cited by this paper
• High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.

  2010cited by this paper
• Abacavir and Cardiovascular Risk: Reviewing the Evidence

  2010cited by this paper
• Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men

  2010cited by this paper
• HBV or HCV Coinfections and Risk of Myocardial Infarction in HIV-Infected Individuals: The D:A:D Cohort Study

  2010cited by this paper
• Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation.

  2010cited by this paper
• Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.

  2010cited by this paper
• Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.

  2010cited by this paper

• Impact of Highly Active Antiretroviral Therapy (HAART) on HIV-Related Cardiomyopathy: A Retrospective Study

  2026cites this paper
• HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection?

  2025cites this paper
• Cardiovascular risk and achievement of target levels in low-density lipoprotein cholesterol in people living with HIV: insights from the DUALIS study

  2025cites this paper
• Spectrum and Correlates of Dyslipidemia in People Living with HIV on Dolutegravir-Based Regimen Attending Kabutare Hospital, Southern Rwanda: A Cross-Sectional Study

  2025cites this paper
• Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE.

  2025cites this paper
• Molecular insights in HIV-associated cardiac dysfunction

  2025cites this paper
• Clonal hematopoiesis in people with advanced HIV and associated inflammatory syndromes

  2024cites this paper
• Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial

  2024cites this paper
• Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial

  2024cites this paper
• No Evidence for an Association of HIV and Antiviral Treatment With Changes in Framingham Cardiovascular Risk Score in the Ndlovu Cohort Study

  2024cites this paper
• Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.

  2024cites this paper
• The Impact of HIV Upon the PCI Results: A Systematic Review and Meta‐Analysis

  2024cites this paper
• Atherosclerosis and HIV: Exploring Cardiovascular Risks and Management.

  2024cites this paper
• Circulating GDF-15: a biomarker for metabolic dysregulation and aging in people living with HIV

  2024cites this paper
• Statin use for cardiovascular disease prevention: perceptions among people living with HIV in the United States

  2024cites this paper
• Distinct inflammatory profiles linked to cardiovascular disease risk in HIV infection: implications for the design of preventive and therapeutic interventions.

  2023cites this paper
• ART and cardiovascular-disease risk in people with HIV.

  2023cites this paper
• [Does pitavastatine prevent atherosclerotic cardiovascular events in people living with HIV on antiretroviral therapy with low to moderate cardiovascular risk, and is it safe?]

  2023cites this paper
• Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.

  2023cites this paper
• Development of Hypertension and Diabetes Mellitus, and Associated Factors, Among Adult HIV Patients in Ethiopia

  2023cites this paper
• Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV

  2022cites this paper
• Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV

  2022cites this paper
• Comparative performance of cardiovascular risk prediction models in people living with HIV

  2022cites this paper
• Two decade trends in cardiovascular disease outcomes and cardiovascular risk factors among US veterans living with HIV

  2022cites this paper
• Prevalence and risk factors of cardiovascular disease among people living with HIV in the Asia-Pacific region: a systematic review

  2022cites this paper
• Risk Factors Attributable to Hypertension among HIV-Infected Patients on Antiretroviral Therapy in Selected Rural Districts of the Eastern Cape Province, South Africa

  2022cites this paper
• Lung function and atherosclerosis: a cross-sectional study of multimorbidity in rural Uganda

  2022cites this paper
• Cardiovascular risks associated with protease inhibitors for the treatment of HIV

  2021cites this paper
• Cytomegalovirus may influence vascular endothelial health in Indonesian HIV-infected patients after 5 years on ART

  2021influential citation
• Predicting cardiovascular risk using a novel risk score in young and middle-age adults with HIV: associations with biomarkers and carotid atherosclerotic plaque

  2021cites this paper
• Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population

  2021cites this paper
• Cardiovascular disease and prevention among people living with HIV in South Florida

  2021cites this paper
• Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk

  2021cites this paper
• Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention

  2021cites this paper
• Treated HIV Infection and Progression of Carotid Atherosclerosis in Rural Uganda: A Prospective Observational Cohort Study

  2021cites this paper
• Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets

  2021cites this paper
• HIV-related Cardiovascular Disease: Any role for High-density Lipoproteins?

  2020cites this paper
• Increased CHIP Prevalence Amongst People Living with HIV

  2020cites this paper
• Effects of Integrase Inhibitor–Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIV

  2020cites this paper
• Cardiovascular Disease Burden in Rural Africa: Does HIV and Antiretroviral Treatment Play a Role?

  2020cites this paper
• Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV‐Infected Adults

  2019cites this paper
• Severe periodontitis is more common in HIV- infected patients.

  2019cites this paper
• Cardiac Dysfunction Among People Living With HIV: A Systematic Review and Meta-Analysis.

  2019cites this paper
• Elevated Microparticle Tissue Factor Activity Is Associated With Carotid Artery Plaque in HIV-Infected Women

  2019cites this paper
• Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.

  2019cites this paper
• Investigation of immune correlates, and impact of human cytomegalovirus and immune activation, on tuberculosis disease risk

  2019cites this paper
• Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes

  2019cites this paper
• Cardiovascular risk factors among ART‐experienced people with HIV in South Africa

  2019influential citation
• A Phase I, Randomized, Controlled Clinical Study of CC-11050 in People Living With HIV With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE).

  2019cites this paper
• Subclinical Atherosclerosis Imaging in People Living with HIV

  2019cites this paper
• Humoral immunity against HDL particle: a new perspective in cardiovascular diseases?

  2019cites this paper
• Dysregulation of sterol regulatory element-binding protein 2 gene in HIV treatment-experienced individuals

  2019cites this paper
• Carotid intima-media thickness is not associated with neurocognitive impairment among people older than 50 years with and without HIV infection from Thailand.

  2019cites this paper
• Of Vesicles and Viruses: Why Statins Are Good for HIV Patients.

  2019cites this paper
• Coronary Microvascular Dysfunction in HIV: A Review

  2019influential citation
• Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort

  2018cites this paper
• Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study

  2018cites this paper
• Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir

  2018cites this paper
• Novel mediators of statin effects on plaque in HIV: a proteomics approach

  2018cites this paper
• Do platelets LINE up for aging?

  2018cites this paper
• Dyslipidemia in the Setting of HIV Infection and Its Management with Statin Therapy Among a Cohort of HIV-Infected Patients in Washington, DC

  2018cites this paper
• Benchmarks of Diabetes Care in Men Living With Treated HIV-Infection: A Tertiary Center Experience

  2018cites this paper
• Human Immunodeficiency Virus Infection And Hypertension. Is There a Connection?

  2018cites this paper
• Carotid Artery Stiffness and Cognitive Decline Among Women With or at Risk for HIV Infection

  2018cites this paper
• Epicardial Adipose Tissue Volume and Cardiovascular Risk Indices among Asymptomatic Women with and without HIV

  2018cites this paper
• Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

  2018cites this paper
• Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS

  2018cites this paper
• The role of interleukin-32 in the increased cardiovascular risk associated with chronic inflammatory diseases

  2018cites this paper
• Regional coronary endothelial dysfunction is related to the degree of local epicardial fat in people with HIV.

  2018cites this paper
• Insulin Resistance in HIV-Patients: Causes and Consequences

  2018cites this paper
• Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV‐positive persons: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study

  2018cites this paper
• HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies

  2018influential citation
• Atherosclerosis in subjects newly diagnosed with human immunodeficiency virus infection

  2018cites this paper
• Cardiovascular disease burden among human immunodeficiency virus-infected individuals.

  2018cites this paper
• Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS

  2018cites this paper
• HIV and risk of cardiovascular disease in sub-Saharan Africa: Rationale and design of the Ndlovu Cohort Study

  2017cites this paper
• The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection

  2017cites this paper
• Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals

  2017cites this paper
• Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275).

  2017cites this paper
• Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial

  2017cites this paper
• WHITE MATTER HYPERINTENSITIES IN RELATION TO COGNITION IN HIV-INFECTED MEN WITH SuSTAINED SuPPRESSED VIRAL LOAD ON CART

  2017cites this paper
• Cardiovascular disease risk among women living with HIV in North America and Europe

  2017cites this paper
• Cardiovascular Disease and Cardiovascular Disease Risk in HIV-Positive Populations in the Asian Region

  2017cites this paper
• HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.

  2017cites this paper
• Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients.

  2017cites this paper
• WHITE MATTER STRuCTuRE ALTERATIONS IN HIV-INFECTED MEN WITH SuSTAINED SuPPRESSION OF VIREMIA ON TREATMENT

  2017cites this paper
• High prevalence of “non-dipping” blood pressure and vascular stiffness in HIV-infected South Africans on antiretrovirals

  2017cites this paper
• Cognitive impairment and MRI-findings in patients with HIV on antiretroviral treatment

  2017cites this paper
• Macrophages and Phospholipases at the Intersection between Inflammation and the Pathogenesis of HIV-1 Infection

  2017cites this paper
• Interventions for Neurocognitive Dysfunction

  2017cites this paper
• White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy

  2016cites this paper
• HIV/AIDS: Emerging threat to cardiovascular health in sub-Saharan Africa

  2016cites this paper
• Transforming growth factor-β1-mediated cardiac fibrosis: potential role in HIV and HIV/antiretroviral therapy-linked cardiovascular disease.

  2016cites this paper
• Pathophysiology and Management of Cardiovascular Disease in HIV-Infected Patients

  2016cites this paper
• Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy

  2016cites this paper
• Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV

  2016cites this paper
• Inflammation, immune activation, and cardiovascular disease in HIV.

  2016cites this paper
• Cardiovascular Disease Risk Prediction in the HIV Outpatient Study.

  2016cites this paper
• Cardiovascular Risk in HIV-Infected and Uninfected Postmenopausal Minority Women: Use of the Framingham Risk Score

  2016cites this paper
• Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV

  2016cites this paper